Medicine
Fluticasone propionate 50 mcg/0.1 g nasal spray
Fluticasone propionate 50 mcg/0.1 g nasal spray is a generic prescription medicine for nasal use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store between 4° and 30°C (39° and 86°F).
Key facts
- Active ingredient (INN)
- Fluticasone propionate
- Brand
- Sold under the generic name
- Strength
- 50 mcg/0.1 g
- Dosage form
- Nasal spray
- Route
- Nasal
- Packs
- 16 g
- Manufacturer
- Asclemed
- Origin register
- US FDA, United States
- Storage
- Store between 4° and 30°C (39° and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.32Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 16 January 2008
- Identifiers
- RxCUI 1797907DailyMed set ID 75049554-64ca-4efa-b8d1-13cf31d0ff90NDC 76420-106Application ANDA077570
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 16 g in 1 bottle, pump | 76420-106-16 | Asclemed | 2 November 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 December 1990 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Fluticasone propionate
Clinical summary
Fluticasone propionate is a corticosteroid indicated for the maintenance treatment of asthma as prophylactic therapy in patients aged 4 years and older, among other approved uses. MedsAcross supplies Fluticasone propionate for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Fluticasone propionateFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- FLUTICASONE PROPIONATE DISKUS prescribing information (Prasco Laboratories) · U.S. National Library of Medicine, DailyMed
Need Fluticasone propionate 50 mcg/0.1 g nasal spray for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.